top of page
ChatGPT Image Feb 28, 2026 at 02_59_56 PM.png

PharmaQuiz

Pregabalin

This section provides a selection of diverse resources intended to support your preparation for and completion of the quiz. The materials may include scientific articles, official reports, practice guidelines, and other relevant documents offering complementary perspectives. Engaging with these resources prior to or during the quiz will help you deepen your understanding of the subject matter, strengthen your analytical approach, and enhance the overall quality of your learning process.

Prégabaline sous la loupe carcérale

Marcot D, Castelan Camargo HC. L’Encéphale. 2023;49:199–201

Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update

Evoy KE, Sadrameli S, Contreras J, Covvey JR, Peckham AM, Morrison MD. Drugs. 2021;81:125–156

A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin

Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek N, Burger P. Clin Pharmacokinet. 2010;49:661–669

Abuse and Misuse of Pregabalin and Gabapentin

Evoy KE, Morrison MD, Saklad SR. Drugs. 2017;77:403–426

Pregabalin for generalized anxiety disorder: systematic review and meta-analysis

Generoso MB, Trevizol AP, Kasper S, Cho HJ, Cordeiro Q, Shiozawa P. Int Clin Psychopharmacol. 2017;32:49–55

How addictive are gabapentin and pregabalin? A systematic review

Bonnet U, Scherbaum N. Eur Neuropsychopharmacol. 2017;27:1185–1215

Pregabalin for the treatment of neuropathic pain: a narrative review

D’Arcy Y, McCarberg B, Parsons B, Behar R, Thorpe A, Alexander A. Curr Med Res Opin. 2017;33:1353–1359

Détournement de la prégabaline à des fins toxicomaniaques

Laribi M, Chaouali N, Jaballah S, Amira D, Hedhili A. Ann Pharm Fr. 2023;81:419–424

CME Certificate

You can download the continuing education certificate here and open it with the password.
You can then enter your name and save or print the certificate.

 

© 2026 Swiss Society of Addiction Medicine

 

bottom of page